Table 1 Table showing the initial and final weight, percentage change in weight and blood glucose levels of mice exposed to Artemether/lumefantrine (A/L) and artesunate/amodiaquine (A/A) compared to the control (CTL)
Exposure periods | Treatment | Initial body Weight (g) | Final body weight (g) | Percentage change in body weight (%) | Blood glucose level |
|---|---|---|---|---|---|
First | CTL | 23.57 ± 0.28 | 25.53 ± 0.38 | 8.39 ± 2.39 | 7.49 ± 0.41 |
A/L | 24.73 ± 0.38 | 25.50 ± 0.26 | 3.18 ± 2.62 | 9.09 ± 0.27 | |
A/A | 22.83 ± 0.41 | 25.87 ± 0.39 | 13.38 ± 3.07 | 7.43 ± 0.04 | |
Second | CTL | 24.53 ± 0.33 | 26.77 ± 0.18 | 9.14 ± 1.68 | 7.33 ± 0.32 |
A/L | 25.30 ± 0.25 | 26.80 ± 0.17 | 5.95 ± 1.32 | 8.11 ± 0.02 | |
A/A | 24.47 ± 0.35 | 26.90 ± 0.29 | 9.98 ± 1.66 | 8.35 ± 0.00 | |
Third | CTL | 25.30 ± 0.25 | 30.10 ± 1.04 | 18.92 ± 3.01 | 7.91 ± 0.09 |
A/L | 23.60 ± 1.15 | 29.70 ± 0.17 | 25.87 ± 1.44 | 8.21 ± 0.08 | |
A/A | 24.47 ± 0.38 | 29.53 ± 0.32 | 20.73 ± 0.58 | 8.25 ± 0.10 | |
Sixth | CTL | 25.27 ± 0.27 | 31.60 ± 0.83 | 29.22 ± 4.14 | 8.39 ± 0.61 |
A/L | 24.63 ± 0.24 | 33.07 ± 0.26 | 30.88 ± 0.59 | 7.68 ± 0.14 | |
A/A | 23.97 ± 0.41 | 32.43 ± 0.32 | 35.38 ± 1.84 | 8.70 ± 0.08 |